Oculus Innovative Sciences, Inc., a specialty pharmaceutical company, introduce two new MicrocynAH dermatology products for animals.
Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.
Oculus Innovative Sciences, Inc., a specialty pharmaceutical company, introduce two new MicrocynAH dermatology products for animals.
A new study has suggested that survivors of childhood brain tumors have lower working memory performance in adulthood compared to healthy adults. The study appeared in the Journal of the International Neuropsychological Society.
B. Braun Medical Inc. (B.Braun), a leader in infusion therapy and pain management, has received 510(k) clearance for its second-generation, large-volume Infusomat Space Pump.
Patients with advanced melanoma skin cancer survive for longer without their disease progressing if they have been treated with a combination of two drugs, nivolumab and ipilimumab, than with either of these drugs alone. New results show that these patients also do better regardless of their age, stage of disease and whether or not they have a cancer-driving mutation in the BRAF gene.
European Commission (EC) has granted marketing authorization for Praluent® (alirocumab) for the treatment of bad cholesterol, known as low-density lipoprotein (LDL) cholesterol, in certain adult patients with hypercholesterolemia. Praluent is the only EC-approved PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor that is available in two starting doses as a single 1-milliter (mL) injection (75 mg and 150 mg) once every two weeks, offering two levels of efficacy. Praluent will be available in a single-dose pre-filled pen that patients self-administer.
Self-assembled DNA nanostructures can be used in molecular-scale diagnostics and as smart drug-delivery vehicles.
Researchers from Aalto University have published an article in the recent Trends in Biotechnology journal. The article discusses how DNA molecules can be assembled into tailored and complex nanostructures, and further, how these structures can find uses in therapeutics and bionanotechnological applications. In the review article, the researchers outline the superior properties of DNA nanostructures, and how these features enable the development of efficient biological DNA-nanomachines. Moreover, these DNA nanostructures provide new applications in molecular medicine, such as novel approaches in tackling cancer. Tailored DNA structures could find targeted cells and release their molecular payload (drugs or antibodies) selectively into these cells.
Pfizer Consumer Healthcare launch Centrum VitaMints, a great-tasting and easy-to-take multivitamin in US Market. Centrum VitaMints is a refreshing and complete multivitamin that provides a more enjoyable experience for consumers to get essential nutrients, and joins other Centrum products to form one of the most comprehensive lines of multivitamins on the market.
Researchers have used non-invasive direct brain control system to get a person, with complete paralysis in both legs owing to spinal cord injury, to walk again. The research was published in the Journal of NeuroEngineering and Rehabilitation.
A new study has revealed that taxol can also be derived from a kind of microbial 'bandage' that protects these trees from disease-causing fungi. This finding may lead to a less expensive synthetic process for making more of the cancer-fighting substance. The study appeared in Current Biology.
A study from 20 countries other than the United States has revealed that people who are treated for addiction are far more likely to smoke. The research team found that people in addiction treatment programs around the world use tobacco at two to three times the rate of people who are not being treated for addiction. The study is published in Addiction.
[adsense:336x280:8701650588]